Fibrosis, inflammation, and osteophyte formation in post-traumatic osteoarthritis
创伤后骨关节炎中的纤维化、炎症和骨赘形成
基本信息
- 批准号:10570315
- 负责人:
- 金额:$ 10.31万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-05-01 至 2025-04-30
- 项目状态:未结题
- 来源:
- 关键词:ATAC-seqAccelerationActinsAffectAgonistArthritisAutomobile DrivingBindingBioinformaticsBiological AssayBiologyBone GrowthBone SpurCartilageCell NucleusCell Surface ReceptorsCellsCharacteristicsChondrocytesChronicClinical ResearchComplexCoupledDataDegenerative polyarthritisDevelopmentDiseaseFibroblastsFibrosisG-Protein-Coupled ReceptorsGoalsHealthHumanHypertrophyImmuneIn VitroInflammationInflammatoryInjectionsInjuryInterleukin-6JointsKineticsKneeKnockout MiceKnowledge acquisitionLabelLeucine-Rich RepeatLinkMacrophageMacrophage ActivationMediatingMentorshipMolecularMolecular BiologyMolecular ImmunologyMultimodal ImagingMusMusculoskeletalMyofibroblastOsteoblastsOsteogenesisOutcomePainPathogenesisPathogenicityPathologicPathologyPatient-Focused OutcomesPhasePopulationPositioning AttributeProcessProteinsProteoglycanReporterReporter GenesResearchRoleScienceSecondary toSeveritiesSignal PathwaySignal TransductionSmooth MuscleSynovial CellSynovial FluidSynovial MembraneSynovitisTechnical ExpertiseTestingTissuesTrainingTransgenic OrganismsTraumatic ArthropathyVocational GuidanceWorkarthropathiesarticular cartilagebeta cateninbonecareercartilage degradationcell typecytokinedisabilityeffective therapyimprovedinducible Creinjuredinsightjoint functionjoint injurymineralizationmultiple omicsneutralizing antibodynovelosteochondral tissueosteogenicpain sensitivitypharmacologicpreclinical studyprogenitorreceptorsingle nucleus RNA-sequencingsingle-cell RNA sequencingskill acquisitionskillstranscriptome sequencing
项目摘要
Post-traumatic osteoarthritis (PTOA) is a degenerative joint disease that arises after injury and affects millions
worldwide. There are currently no disease-modifying treatments. PTOA is a complex, multi-tissue joint disease
characterized by pain, cartilage degradation, synovial inflammation and fibrosis, and formation of ectopic bone
growths called osteophytes. The inherent complexity of this disease is a barrier to developing effective
treatments, as little is known about the intricate tissue crosstalk that underlies PTOA progression. Our long-
term goal is to uncover and comprehensively characterize cellular and molecular mechanisms central to key
pathological sequalae of PTOA: synovial fibrosis, inflammation, and osteophyte formation. We will focus on
canonical Wnt/β-catenin (cWnt) signaling. cWnt overactivation has recently been implicated as a driving factor
of arthritis. Our data show that the cWnt signaling agonist R-spondin 2 (Rspo2) is strongly induced in multiple
joint tissues during PTOA, and that Rspo2 alone is sufficient to induce pathological features characteristic of
PTOA. Using single-cell RNA-seq, we profiled synovium of mice with PTOA and found that Rspo2 is produced
by synovial lining fibroblasts. We identified a novel population of pro-fibrotic cells that arise after injury and
express Lgr cell surface receptors for Rspo2. We showed that synovial fibroblasts respond to Rspo2 by
secreting cytokines that in turn activate pro-inflammatory macrophages (known to drive synovial pathology in
PTOA). Single-cell profiling also revealed a novel subset of injury-induced, Lgr-expressing osteochondral
progenitors in synovium, which we propose give rise to osteophytes. We hypothesize that Rspo2-driven cWnt
signaling mediates pathological crosstalk between joint-resident cell types to potentiate PTOA. To test this, our
aims in the K99 phase are to: 1) determine the role of Rspo2-driven cWnt signaling in the emergence and
function of pro-fibrotic synovial cells during PTOA using transgenic reporter mice, multi-omic analyses, and in
vitro differentiation assays, and 2) characterize crosstalk between cWnt-active synovial fibroblasts and pro-
inflammatory macrophages, using knockout mice and crosstalk assays. To extend upon my molecular biology
and immunology expertise, I will receive rigorous technical and conceptual training from my diverse mentorship
committee during the K99 phase, and valuable career guidance. This expert training in bioinformatics; cWnt
signaling; bone, cartilage, and synovial biology; and multi-modal imaging, will be crucial for carrying out my
K99 aims and especially critical for successfully launching my independent career. These skills will be utilized
in my R00 phase to: 3) determine how Rspo2/Lgr signaling promotes osteophyte formation in PTOA, using
tissue-specific deletion and reporter mice, and in vitro differentiation assays. This work will significantly extend
our understanding of cellular and molecular mechanisms that underpin synovial fibrosis, inflammation, and
osteophyte formation in PTOA. These insights will have meaningful, tangible outcomes for human health, by
accelerating development of effective disease-modifying treatments for PTOA sufferers.
创伤后骨关节炎 (PTOA) 是一种退行性关节疾病,在受伤后出现,影响数百万人
PTOA 是一种复杂的多组织关节疾病,目前在世界范围内尚无缓解疾病的治疗方法。
其特点是疼痛、软骨退化、滑膜炎症和纤维化以及异位骨的形成
这种疾病固有的复杂性是有效发展的障碍。
治疗,因为我们对 PTOA 进展背后的复杂组织串扰知之甚少。
长期目标是揭示并全面表征关键的细胞和分子机制
PTOA的病理后遗症:滑膜纤维化、炎症和骨赘形成。
典型的 Wnt/β-连环蛋白 (cWnt) 信号传导最近被认为是一个驱动因素。
我们的数据表明,cWnt 信号激动剂 R-spondin 2 (Rspo2) 在多种疾病中被强烈诱导。
PTOA 期间的关节组织,并且单独的 Rspo2 足以诱发以下特征的病理特征:
PTOA。使用单细胞 RNA-seq,我们对具有 PTOA 的小鼠滑膜进行了分析,发现产生了 Rspo2。
我们发现了一种新的促纤维化细胞群,这些细胞在损伤和损伤后出现。
表达 Rspo2 的 Lgr 细胞表面受体 我们发现滑膜成纤维细胞通过 Rspo2 做出反应。
分泌细胞因子,进而激活促炎巨噬细胞(已知可驱动滑膜病理学)
单细胞分析还揭示了损伤诱导的、表达 Lgr 的骨软骨的新亚群。
我们认为滑膜中的祖细胞会产生骨赘,我们勇敢地面对 Rspo2 驱动的 cWnt。
信号传导介导联合驻留细胞类型之间的病理串扰以增强 PTOA 为了测试这一点。
K99 阶段的目标是:1) 确定 Rspo2 驱动的 cWnt 信号传导在出现和发生中的作用。
使用转基因报告小鼠、多组学分析和在 PTOA 期间促纤维化滑膜细胞的功能
体外分化测定,2) 表征 cWnt 活性滑膜成纤维细胞和亲-
炎症巨噬细胞,使用基因敲除小鼠和串扰测定来扩展我的分子生物学。
和免疫学专业知识,我将从多元化的指导中接受严格的技术和概念培训
K99 阶段的委员会,以及生物信息学领域的专家培训;
信号传导;骨骼、软骨和滑膜生物学;以及多模态成像,对于开展我的研究至关重要。
K99 的目标对于成功开展我的独立职业生涯尤其重要。我将利用这些技能。
在我的 R00 阶段:3) 确定 Rspo2/Lgr 信号如何促进 PTOA 中骨赘形成,使用
组织特异性缺失和报告小鼠以及体外分化测定将显着扩展这项工作。
我们对滑膜纤维化、炎症和滑膜纤维化的细胞和分子机制的理解
PTOA 中骨赘的形成,这些见解将为人类健康带来有意义、切实的成果。
加速开发针对 PTOA 患者的有效疾病缓解疗法。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Alexander John Knights其他文献
Alexander John Knights的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
相似国自然基金
高功率激光驱动低β磁重联中磁岛对电子加速影响的研究
- 批准号:12305275
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
U型离散顺流火蔓延非稳态热输运机理与加速机制研究
- 批准号:52308532
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
实施科学视角下食管癌加速康复外科证据转化障碍机制与多元靶向干预策略研究
- 批准号:82303925
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
TWIST1介导的ITGBL1+肿瘤相关成纤维细胞转化加速结肠癌动态演化进程机制及其预防干预研究
- 批准号:82373112
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
NOTCH3/HLF信号轴驱动平滑肌细胞表型转化加速半月板退变的机制研究
- 批准号:82372435
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
相似海外基金
Understanding the Role of GARP Proteins in Rod Outer Segment Disc Formation and Retinal Degeneration
了解 GARP 蛋白在视杆外节盘形成和视网膜变性中的作用
- 批准号:
10748725 - 财政年份:2023
- 资助金额:
$ 10.31万 - 项目类别:
Enhanced Viro-Immunotherapy for Breast Cancer Brain Metastasis
乳腺癌脑转移的增强病毒免疫疗法
- 批准号:
10803696 - 财政年份:2023
- 资助金额:
$ 10.31万 - 项目类别:
Role of C. elegans RAPGEF in Synapse Development at the Neuromuscular Junction
线虫 RAPGEF 在神经肌肉接头突触发育中的作用
- 批准号:
10676616 - 财政年份:2023
- 资助金额:
$ 10.31万 - 项目类别:
Project 2 - Verification and Molecular Mechanisms of T1D Modifier Mutations
项目2-T1D修饰突变的验证和分子机制
- 批准号:
10642554 - 财政年份:2023
- 资助金额:
$ 10.31万 - 项目类别: